Skip to main content
An official website of the United States government

Funded Grants

Grants awarded in the current fiscal year and carried over from prior fiscal years.

PI Name PI Organization Title Grant Number Initiative Program Official Sort ascending
Skubitz, Amy Patrice

University Of Minnesota
United States

A paradigm shift for ovarian cancer biomarkers: Utilizing routine Pap tests as liquid biopsies for the development of targeted mass spectrometry-based proteomic assays for early detection 5R01CA262153-05 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Christos Patriotis, Ph.D., M.Sc.
Liang, Han

University Of Tx Md Anderson Can Ctr
United States

The Cancer Proteome Atlas: an Integrated Bioinformatics Resource for Functional Cancer Proteomic Data 5U24CA264128-04 Christos Patriotis, Ph.D., M.Sc.
Wang, Tza-Huei Jeff

Johns Hopkins University
United States

Development of a low-cost epigenetic screening assay for Pap specimen-based detection of early-stage ovarian cancer in high-risk women 5R01CA260628-05 Christos Patriotis, Ph.D., M.Sc.
Wu, Yun

State University Of New York At Buffalo
United States

Lung Cancer Early Detection and Immunotherapy Response Prediction and Monitoring with an Exo-PROS Liquid Biopsy Assay 4R01CA272827-04 Christos Patriotis, Ph.D., M.Sc.
Yaghjyan, Lusine

University Of Florida
United States

Stromal contributions to breast carcinogenesis 5R01CA277817-03 Christos Patriotis, Ph.D., M.Sc.
Fiol, Guilherme Del

Utah State Higher Education System--University Of Utah
United States

GARDE: Scalable Clinical Decision Support for Individualized Cancer Risk Management 5U24CA274582-03 Christos Patriotis, Ph.D., M.Sc.
Zhu, Yong

Univ Of Arkansas For Med Scis
United States

Explore piRNAs as a novel group of biomarkers for ovarian cancer early detection 1R21CA277412-01A1 Christos Patriotis, Ph.D., M.Sc.
Hansen, Laura A

Creighton University
United States

Targeting aberrant anti-apoptotic signaling for prevention of skin cancer 5R01CA253573-05 Howard L. Parnes, M.D.
Kumar, Nagi B.

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Phase II Clinical trial of GTC in Men on Active Surveillance 5R01CA235032-06 Howard L. Parnes, M.D.
Cohn, Barbara A

Public Health Institute
United States

Discriminatory Mechanisms in Early-Onset and Lethal Prostate Cancer 5R01CA264519-05 Howard L. Parnes, M.D.